An interventional study of Whey protein supplement and Ketogenic aid in Overweight and Obesity, sponsored by University of Arkansas, Fayetteville. Recruiting at 1 site in United States. Open to participants aged 25 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-26.
Sponsored by University of Arkansas, Fayetteville · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Effective nutrition strategies for combatting and/or preventing obesity still need to be identified. This has been the case despite the numerous and different approaches that have been taken. Potential targets for combatting/preventing obesity have been identified, but long-term solutions have not emerged. This study uses time restricted feeding to study the role of dietary protein in obesity prevention and/or treatment. The objectives are to determine the role of skeletal muscle mass as a driver of energy-sensing mechanisms and peripheral signals that regulate appetite and energy intake in overweight and obese adults and to determine the effects of protein timing on muscle mass to regulate appetite and energy intake in overweight and obese adults.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
This study's planned enrollment of 90 is above the median of 67 across 9,043 interventional studies indexed under Obesity.
Browse Obesity studies →University of Arkansas, Fayetteville is the lead sponsor of 29 studies on the registry; 7 are open to participants now.
Compared within Obesity, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Overweight. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Follows time restricted feeding protocol.
Other: Control group - time restricted feeding only
Follows time restricted feeding protocol, consumes protein supplement
Dietary Supplement: Whey protein supplement
Follows time restricted feeding protocol, consumes ketogenic supplement
Dietary Supplement: Ketogenic aid
Participants consume whey protein at the beginning of the eating period.
Participants consume ketogenic aid upon waking.
Time restricted feeding.
Body composition
Body composition measured using dual x-ray absorptiometry to determine the ration of lean/fat-free mass to fat mass.
Time frame: Change is being assessed at baseline and final day (day 120) of the intervention.
Whole body protein turnover
Whole body protein turnover will be measured using 15N-alanine
Time frame: Change is being assessed at baseline and final day (day 120) of the intervention.
Muscle mass
Muscle mass will be measured using D3-creatine
Time frame: Change is being assessed at baseline and final day (day 120) of the intervention.
Body weight
Body weight will be measured in kilograms.
Time frame: Change is being assessed at baseline, 4, 8, and 12 weeks.
Sleep
Sleep will be assessed using wrist Actigraphy for sleep duration and total time in bed.
Time frame: Change is being assessed at baseline and 12 weeks
Sleep Quality
Sleep quality will be measured using the Pittsburgh Sleep Quality Index survey
Time frame: Change is being assessed at baseline, 4, 8, and 12 weeks
Mood
Mood will be assessed using the Profile of Mood States Questionnaire
Time frame: Change is being assessed at baseline, 4, 8, and 12 weeks
Grit
Grit will be assessed using the grit questionnaire.
Time frame: Change is being assessed at baseline, 4, 8, and 12 weeks
Self-reported physical activity
Physical activity will be measured using the iPAQ survey
Time frame: Change is being assessed at baseline, 4, 8, and 12 weeks
Dietary intake
Dietary intake will be measured using weighed, 3-day food records
Time frame: Change is being assessed at baseline, 4, 8, and 12 weeks
Fasting glucose
Glucose will be measured as mg/dl
Time frame: Change is being assessed at baseline, 4, 8, and 12 weeks
Hand grip
Hand grip will be measured using a dynamometer.
Time frame: Change is being assessed at baseline, 4, 8, and 12 weeks
Amino acids and metabolites
Blood will be collected and plasma amino acids and metabolites will be assessed using commercially available kit for amino acid analysis for all circulating amino acids.
Time frame: Change is being assessed at baseline, 4, 8, and 12 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Jun 2021 to primary completion in Apr 2025, 46 months.
Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 46 months is above that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Arkansas, Fayetteville